Two years into the pandemic, it’s clear that decentralized clinical trials are here to stay. Approximately 70 percent of patients live more than 2 hours from clinical trial sites. Therefore, decentralized or hybrid studies can improve patient centricity in clinical trials by reducing patient burden and improving patient retention.

Join decentralized clinical trial experts in this complimentary webinar to explore industry trends, operational obstacles and the evolving patient journey. The featured speakers will examine components of a patient-focused, flexible supply chain strategy. In addition, there will be a discussion about how sponsors and investigator sites can benefit from pandemic-era lessons learned.

In this webinar, attendees will learn about:

• Impact of COVID-19 on clinical trial study design — decentralized clinical trials are here to stay
• Studies that focus on the patient experience offer significant advantages to sponsors
• Technology, data integration and an agile supply chain strategy together are key for success